Mirae Asset Global ETFs Holdings
VRCA icon

Mirae Asset Global ETFs Holdings’s Verrica Pharmaceuticals VRCA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,159
Closed -$9.55K – 3251
2025
Q1 		$9.55K Buy
2,159
+1,073
+99% +$6.94K ﹤0.01% 3023
2024
Q4 		$7.6K Buy
1,086
+46
+4% +$506 ﹤0.01% 3034
2024
Q3 		$15.1K Sell
1,040
-99
-9% -$4.46K ﹤0.01% 3026
2024
Q2 		$83K Buy
+1,139
New +$87.5K ﹤0.01% 2634

Other funds holding VRCA

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SA
Sovran Advisors San Diego, California $1.27B AUM 18.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's VRCA Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Verrica Pharmaceuticals (VRCA) in Q2 2025, closing a stake of 2,159 shares — an estimated $9.55K sold.

Mirae Asset Global ETFs Holdings first reported a position in VRCA in Q2 2024 and held it in 4 quarters. The position peaked at $83K in Q2 2024. 58 funds tracked by Wall St. Rank hold VRCA as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining Verrica Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 2,159 Verrica Pharmaceuticals shares in Q2 2025, an estimated $9.55K.
  • Mirae Asset Global ETFs Holdings first reported a position in Verrica Pharmaceuticals in Q2 2024 and held it in 4 quarters.
  • Mirae Asset Global ETFs Holdings's Verrica Pharmaceuticals position peaked at $83K in Q2 2024.
  • 58 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.